s.roos

TL2 · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 15 November 2024 · last posted 4d

87 posts, newest first. Showing up to 150.

Coming back to: Time to steady state after a dose increase Replied, post #109 · Pharmacology › Pharmacokinetics · 24 Jul 2026 · 11 likes The arithmetic in post #108 is right; the assumption feeding it is the part to check. Washout after stopping takes roughly the same four to five half-lives as reaching…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #62 · Analytics › HPLC & UHPLC · 23 Jul 2026 · 4 likes Checked the Detection wavelength claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #78 · Compounds › Retatrutide · 20 Jul 2026 · 11 likes Taking post #77 at face value and following it one step further. Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by…
Spreadsheets: an appreciation — what changed since Replied, post #105 · Lounge › Off topic · 19 Jul 2026 · 0 likes Spreadsheets is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Pooling trials with different estimands Replied, post #94 · Evidence › Meta-analyses · 13 Jul 2026 · 6 likes Quality assessment of included trials should change the analysis rather than sit beside it. A sensitivity analysis excluding the weakest studies is the minimum. That is…
Reused chromatograms across lots: how to spot it Replied, post #56 · Analytics › COA interpretation · 10 Jul 2026 · 30 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #12 · Practice › Interactions · 4 Jul 2026 · 2 likes Taking post #11 at face value and following it one step further. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #29 · Practice › Side effects · 4 Jul 2026 · 0 likes The practical version of Muscle cramps is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Personal or family history of medullary thyroid carcinoma Replied, post #28 · Safety › Contraindications · 29 Jun 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Asking a follow-up: new topic or new reply? Replied, post #29 · Start Here › How to Ask · 29 Jun 2026 · 0 likes The question underneath asking a follow-up is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #28 · Access › International · 21 Jun 2026 · 4 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #59 · Analytics › Method validation · 19 Jun 2026 · 0 likes Post #55 and I disagree about the size of the effect, not about the direction. Accuracy: the method measures what you intend to measure. For purity methods, this is…
Second pass at: The storage lookup and where its data comes from Replied, post #30 · Data & Tools › Calculators · 13 Jun 2026 · 20 likes The version of storage lookup that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #18 · Practice › Administration · 7 Jun 2026 · 19 likes I read post #14 twice before replying, because I had assumed the opposite. Two questions I would want answered before drawing anything from the Leak-back data above:…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #11 · Pharmacology › Pharmacokinetics · 30 May 2026 · 0 likes Post #7 and I disagree about the size of the effect, not about the direction. Half-life determines how quickly concentration approaches steady state and does not…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #72 · Practice › Reconstitution · 25 May 2026 · 6 likes This follows post #71 rather than contradicting it. Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only…
Second pass at: Absence of evidence and evidence of absence Replied, post #5 · Research Methods › Statistics · 18 May 2026 · 13 likes Adding the measurement that post #2 says would settle it. One more thing on Absence of evidence that took me far too long to see: the two figures people quote are not…
The anatomy of a question that gets answered within an hour Replied, post #42 · Start Here › How to Ask · 11 May 2026 · 0 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition.
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #5 · Evidence › Meta-analyses · 10 May 2026 · 22 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. None of the above is…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #26 · Compounds › Tirzepatide · 6 May 2026 · 0 likes Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
Follow-up: Search filters: what is missing Replied, post #90 · Meta › Site feedback · 30 Apr 2026 · 21 likes Worth separating two things that post #88 runs together. Feature requests: if the site would work better with a feature it does not have (better search, different…
[2026 update] Composite endpoints and the component doing the work Replied, post #84 · Evidence › Trials · 24 Apr 2026 · 18 likes Where I part company with post #80, and it is a narrow parting. Small methodological point on Composite endpoints: repeating a measurement is cheap and resolves most of…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #62 · Clinical › Special populations · 5 Mar 2026 · 3 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. The strength of my…
Contributing data without breaching anyone's privacy Replied, post #3 · Data & Tools › Datasets · 2 Mar 2026 · 27 likes Where a value is derived rather than measured, mark it. Derived columns get treated as observations the moment the file leaves your hands.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #121 · Practice › Interactions · 27 Feb 2026 · 9 likes Saving this. It is the version I will quote when the question comes round again.
Cost per delivered dose, which is the number that matters Replied, post #50 · Access › Pricing · 20 Feb 2026 · 24 likes Where somebody posts a comparison, the useful version states the date, the region and what was included. Happy to be corrected if someone holds better data than mine.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #134 · Analytics › COA interpretation · 17 Feb 2026 · 22 likes Post #131 is right about the mechanism and I think understates the practical bit. A document that puts the specification in the result column has told you the release…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #25 · Evidence › Trials · 9 Feb 2026 · 2 likes Speaking only to Non-inferiority margins as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
Alcohol: what is documented and what is folklore — the long version Replied, post #14 · Practice › Interactions · 3 Feb 2026 · 2 likes Worth separating two things that post #10 runs together. A request rather than an answer: could whoever has the primary source for Alcohol post it? I have seen the…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #60 · Compounds › Semaglutide · 27 Jan 2026 · 4 likes Coming back to post #58, because the follow-up matters more than the original answer. Injection site does not appear to matter much for semaglutide exposure. The…
Bioimpedance and hydration: why the number moves Started this topic · Outcomes › Body composition · 19 Jan 2026 · 7 likes Bioimpedance and hydration: why the number moves — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #19 · Practice › Side effects · 14 Jan 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #72 · Clinical › Special populations · 10 Jan 2026 · 13 likes I read post #68 twice before replying, because I had assumed the opposite. The most useful contribution here is usually a citation to whichever published document comes…
[2026 update] Availability by country, dated, with primary sources Replied, post #8 · Access › International · 3 Jan 2026 · 4 likes Availability is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Heterogeneity as information rather than as a nuisance Replied, post #37 · Evidence › Meta-analyses · 25 Dec 2025 · 11 likes That reframing is the whole thing. The facts I already had.
Preprint servers and what screening they do Replied, post #2 · Evidence › Preprints · 16 Dec 2025 · 23 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Trying to state the preprint servers position in a way…
Angle of injection and whether 90 degrees is always right Replied, post #66 · Practice › Administration · 15 Dec 2025 · 16 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
DXA precision and the least significant change for lean mass Replied, post #70 · Outcomes › Body composition · 14 Dec 2025 · 22 likes Noted, and thank you for writing it out rather than summarising it.
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #24 · Safety › Contraindications · 13 Dec 2025 · 23 likes Narrowing post #23, because the general version has more than one answer. The claim about Severe gastroparesis upthread is stronger than its source supports. I have…
Tracking a preprint to publication: a worked example Replied, post #51 · Evidence › Preprints · 5 Dec 2025 · 6 likes Post #50 answers the question as asked. The question underneath it is different. Check whether it was later published: searching for the preprint's first author and…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #33 · Analytics › Method validation · 4 Dec 2025 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
[2026 update] Reporting a disappointing outcome, and why it belongs here Replied, post #2 · Outcomes › Progress reports · 25 Nov 2025 · 21 likes That matches what I have seen, for whatever a single anecdote is worth.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #52 · Compounds › Oral incretins · 20 Nov 2025 · 29 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
Pen dose counters: what a click does and does not guarantee Replied, post #107 · Devices › Pens & autoinjectors · 19 Nov 2025 · 18 likes Worth separating two things that post #103 runs together. The residual left in a cartridge at the end is deliberate overfill and is not a dose you are entitled to…
Second pass at: The mass-error checker and its intended scope Replied, post #57 · Data & Tools › Calculators · 7 Nov 2025 · 13 likes One caution on mass-error checker: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #75 · Practice › Reconstitution · 31 Oct 2025 · 1 like Post #72 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
Sleep tracking data and its considerable limitations Replied, post #116 · Wellbeing › Sleep · 28 Oct 2025 · 5 likes Thank you for the correction. I would rather find out here than later.
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #13 · Practice › Side effects · 21 Oct 2025 · 28 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
Thyroid function tests during substantial weight change Replied, post #88 · Clinical › Bloodwork · 8 Oct 2025 · 4 likes Right, and stated more narrowly than I would have dared to state it.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #14 · Analytics › HPLC & UHPLC · 28 Sep 2025 · 29 likes A relative retention time against a known peak travels much better than an absolute one, and almost nobody reports it. The general case is well covered; this is the…
What pooling buys you and what it destroys Replied, post #28 · Evidence › Meta-analyses · 24 Sep 2025 · 0 likes Post #27 is the version of this I will quote in future. One addition. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #4 · Compounds › Tirzepatide · 21 Aug 2025 · 0 likes What I want from this dual agonism thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
A ten-fold dose error caught before injection Replied, post #81 · Devices › Syringes & needles · 13 Aug 2025 · 19 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. I would…
A ten-fold dose error caught before injection — one year on Replied, post #10 · Devices › Syringes & needles · 1 Aug 2025 · 18 likes I read post #9 twice before replying, because I had assumed the opposite. Before the thread moves on from ten-fold dose error caught — what is the sample size behind…
High-resolution MS on aggregates and what it can see Replied, post #33 · Analytics › Mass spectrometry · 30 Jul 2025 · 1 like Resolution: "high resolution" commonly means
How to research a compound with no human data without deceiving yourself Replied, post #2 · Compounds › Other compounds · 29 Jul 2025 · 0 likes Anything in this subcategory with a published trial behind it should be discussed separately from anything without one. Mixing them produces a discussion where the…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2025 · 0 likes I read post #60 twice before replying, because I had assumed the opposite. I have three months of notes on cagrisema phase 2 paper and the honest summary is that the…
About the Tirzepatide category Replied, post #4 · Compounds › Tirzepatide · 24 Jun 2025 · 9 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Repeatability versus intermediate precision Replied, post #13 · Analytics › Method validation · 18 Jun 2025 · 16 likes This follows post #12 rather than contradicting it. System suitability is the ongoing evidence that a validated method is still performing. Validation is done once;…
A report I filed that turned out to be wrong, and the correction Replied, post #77 · Sourcing › Vendor reports · 30 May 2025 · 0 likes Picking up post #75: that is the part I would want checked first. The format we ask for is compound, lot, testing service, method as reported, result, and the…
A claim built entirely on a subgroup analysis Replied, post #47 · Evidence › Study critique · 21 May 2025 · 0 likes A request rather than an answer: could whoever has the primary source for claim built post it? I have seen the claim three times this month and each version had lost a…
Lean mass preservation: what the evidence supports Replied, post #25 · Outcomes › Body composition · 20 May 2025 · 14 likes Where the lean mass preservation discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #153 · Sourcing › Regulatory · 15 May 2025 · 0 likes The arithmetic in post #152 is right; the assumption feeding it is the part to check. The documentation on Research-use-only labelling is better than this thread and I…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #87 · Sourcing › Independent verification · 13 May 2025 · 31 likes On post #84 — agreed on the reasoning, with one qualification. Where an independent figure and a declared figure differ by less than method repeatability, that is…
Fibre intake when total intake falls, and the constipation link Replied, post #61 · Nutrition & Training › Protein & intake · 1 May 2025 · 0 likes I read post #59 twice before replying, because I had assumed the opposite. Fibre intake has been discussed here with more heat than it deserves, mostly because two…
State-level differences that actually matter Replied, post #3 · Regional › North America · 9 Apr 2025 · 13 likes Building on post #2 rather than restating it. Cost comparisons should state whether they include the device and the dispensing fee, because those differ between routes…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #35 · Compounds › Other compounds · 25 Mar 2025 · 23 likes Taking post #33 at face value and following it one step further. Solubility varies far more across this subcategory than within the incretins. A compound that needs a…
Retatrutide dose escalation in the published trials Replied, post #37 · Compounds › Retatrutide · 22 Mar 2025 · 5 likes The hepatic-steatosis rationale follows directly from glucagon receptor agonism promoting fat oxidation in the liver. Mechanistic plausibility in this field has a poor…
When "no data" is the complete and final answer Replied, post #125 · Compounds › Other compounds · 22 Mar 2025 · 8 likes Good question, well framed, and I would like to see it answered properly.
Charge states for a 4 kDa peptide, worked through Replied, post #77 · Analytics › Mass spectrometry · 11 Mar 2025 · 21 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #78 · Pharmacology › Receptor biology · 11 Mar 2025 · 0 likes Filing a mild objection to the consensus on biased agonism. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #94 · Compounds › Semaglutide · 9 Mar 2025 · 4 likes I came in to disagree and I am leaving without a disagreement.
What a seizure notice actually says Replied, post #30 · Sourcing › Logistics · 4 Feb 2025 · 0 likes Post #29 is right about the mechanism and I think understates the practical bit. Document outcomes rather than forecasting them. A forecast in this category reads as…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #36 · Compounds › Semaglutide · 24 Dec 2024 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Coming back to: When to suspect the method rather than the sample Replied, post #77 · Analytics › Method validation · 15 Dec 2024 · 18 likes Sample stability during analysis is part of validation and is routinely ignored. A preparation that degrades in the autosampler over eight hours produces a…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #51 · Meta › Wiki maintenance · 29 Nov 2024 · 0 likes Where I part company with post #47, and it is a narrow parting. The convention is to label them explicitly as community practice in the sentence. It is not always…
Second opinions: how to seek one without burning the first Replied, post #3 · Clinical › Prescriber conversations · 13 Nov 2024 · 32 likes The opening post and I disagree about the size of the effect, not about the direction. Take the actual numbers and the actual dates. A printed table beats a description…
Time to steady state after a dose increase Replied, post #50 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Post #48 and I disagree about the size of the effect, not about the direction. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and…
US compounding rules and how they changed Replied, post #39 · Regional › North America · 24 Oct 2024 · 0 likes Post #38 is right about the mechanism and I think understates the practical bit. Say which country and which state or province. Regulatory position, availability and…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #106 · Sourcing › Independent verification · 3 Oct 2024 · 25 likes Adding a data point of agreement rather than a data point.
When a red flag was a misunderstanding, and the retraction Replied, post #26 · Sourcing › Red flags · 1 Oct 2024 · 0 likes Answering the question post #24 raises rather than the one it answers. Red flag is well covered in the tag pages, and the older discussions are better than the recent…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #37 · Practice › Administration · 18 Sep 2024 · 3 likes Small correction to my own earlier position on site rotation scheme. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
Promotion criteria, and the one that stops most nominations Replied, post #60 · Documentation › Doc review · 13 Sep 2024 · 12 likes I read post #58 twice before replying, because I had assumed the opposite. The arithmetic on promotion criteria is the easy part and it is where the errors are, which…
Anxiety in the first weeks: drug, situation, or both Started this topic · Wellbeing › Mental health · 10 Sep 2024 · 24 likes On the subject in the title: Anxiety in the first weeks: drug, situation, or both Working notes rather than a conclusion. The question about anxiety that I actually…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Started this topic · Compounds › Cagrilintide & amylin analogues · 8 Sep 2024 · 7 likes Amylin analogue mechanism: satiety signalling separate from GLP-1 — setting out what I have, and where I think it stops being reliable. Trying to work out what would…
Cold packs, phase-change material, and what survives ten days Replied, post #136 · Sourcing › Logistics · 23 Jul 2024 · 0 likes I have been on both sides of the cold packs argument in this category within eighteen months, which should tell you how strong the evidence for either side is.